Indivior wins preliminary injunction preventing Dr Reddy’s from selling Suboxone copycat

04:50 EDT 16 Jul 2018 | Proactive Investors

The injunction grant gives Indivior some much-needed breathing space, but it could all be in vain if US authorities eventually decide that Dr Reddy’s drug doesn’t infringe on any patents

More From BioPortfolio on "Indivior wins preliminary injunction preventing Dr Reddy’s from selling Suboxone copycat"